Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Arch. endocrinol. metab. (Online) ; 62(2): 179-186, Mar.-Apr. 2018. tab, graf
Article in English | LILACS | ID: biblio-887646

ABSTRACT

ABSTRACT Objective Adipose tissue, particularly visceral adipose tissue, secretes a variety of cytokines, among which progranulin is a glycoprotein related to the immune system. Along with other secreted proteins, progranulin may be associated with bone mineral density. The aim of this study was to find out whether there are associations between the progranulin and bone mineral density among obese people. Subjects and methods This cross-sectional study was conducted on 244 obese participants (aged 22-52). Serum progranulin, high sensitive C-reactive protein, oxidised-low dencity lipoprotein, tumor necrosis factor-α, parathormone, vitamin D, and interleukins of 1 β, 4, 6, 10, 13, and 17 concentrations were measured. Anthropometric measurements, body composition and bone mineral density were also assessed. Results Serum progranulin was directly associated with interleukin-6 and interleukin-1β, while it had a negative association with interleukin-17 and tumor necrosis factor-α. We also observed a statistically significant direct association between progranulin concentration and visceral fat, abdominal fat, waist, abdominal and hip circumferences, hip T-score, and Z-score and T-score for the lumbar region. A partial correlation test has also shown a significant positive correlation regarding serum progranulin and the hip Z-score. Moreover, progranulin level is inversely associated with ospteopenia (P = 0.04 and CI: 0.17,0.96). Conclusion Our study revealed that central obesity may be related to increased progranulin concentration. In addition, progranulin concentration was directly related to bone formation parameters, which indicates the protective effects of progranulin on bone density. Further studies are needed to clarify the exact mechanisms underlying these associations.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Young Adult , Bone Density/physiology , Intercellular Signaling Peptides and Proteins/blood , Obesity/blood , Osteoporosis/blood , Parathyroid Hormone/blood , Reference Values , Vitamin D/blood , Body Composition , C-Reactive Protein/analysis , Absorptiometry, Photon , Sex Factors , Anthropometry , Adipose Tissue/metabolism , Cross-Sectional Studies , Interleukins/blood , Tumor Necrosis Factor-alpha/blood , Progranulins , Lipoproteins, LDL/blood
2.
Rev. Col. Bras. Cir ; 45(5): e1968, 2018. tab, graf
Article in Portuguese | LILACS | ID: biblio-976932

ABSTRACT

RESUMO Objetivo: examinar os efeitos da sinvastatina na mucosite gástrica e intestinal após o tratamento com 5-fluorouracil (5-FU), determinados pela expressão de citocinas e histologia em ratos. Métodos: ratos pesando 270±15g foram divididos em dois grupos. O grupo 5-FU+salina foi tratado com 5-FU (50mg/kg) mais solução salina a 0,9% por gavagem uma vez ao dia por cinco dias. O grupo 5-FU+sinvastatina foi tratado com 5-FU (50mg/kg), mais sinvastatina (10mg/kg), da mesma forma. Foi feita a eutanásia dos animais no sexto dia. O estômago e o intestino foram fotografados e removidos para exame. Dosagens séricas de TNF-a, IL-1ß, IL-6 e histopatologia (coloração HE) do estômago e intestino foram realizadas. Resultados: o peso corporal diminuiu em ratos no grupo 5-FU+salina. A sinvastatina não inibiu a perda de peso induzida pelo 5-FU. Danos significativos da mucosa no estômago e no jejuno foram observados em ratos que receberam apenas 5-FU. As dosagens séricas de citocinas foram significativamente menores no grupo 5-FU+sinvastatina do que no grupo 5-FU (p<0,05). A sinvastatina causou efeitos protetores significativos contra as lesões da mucosa gástrica e jejunal induzidas por 5-FU. Conclusão: a sinvastatina atenua a mucosite gástrica e intestinal relacionada à terapêutica com 5-FU. Nossos dados encorajam futuros estudos pré-clínicos e clínicos sobre a utilidade das estatinas na prevenção da mucosite gastrointestinal.


ABSTRACT Objective: simvastatin has pleiotropic anti-inflammatory and immunomodulatory effects potentially usefull to prevent chemotherapy-induced gastrointestinal mucositis. Studies on this are scarce. This study aimed to examine the effects of simvastatin on gastric and intestinal mucositis after 5-fluorouracil (5-FU) treatment in rats. Methods: rats weighing 270±18g were divided into two groups. The 5-FU+saline group (5-FU/SAL) rats were treated with 5-FU (50mg/kg) plus 0.9% saline orally (gavage) once daily for five days. The 5-FU+simvastatin (5-FU/SIMV) group was treated with 5-FU (50mg/kg), plus simvastatin (10mg/kg), in the same way. The rats were euthanased on the sixth day, then their stomach and intestine were photographed and removed for exams. Dosages of serum TNF-a, IL-1ß, IL-6 and histopathology were done for stomach and intestine. Results: body-weight was significantly lower in rats treated with 5-FU+saline than the weight loss of the 5-FU/SIMV group rats. TNF-a expression was lower in 5-FU/SIMV group (172.6±18pg/ml) than in 5-FU/SAL (347.5±63pg/ml). Serum IL-1b was lower in 5-FU/SAL group (134.5±23pg/ml) than in 5-FU/SIMV (48.3±9pg/ml). Serum IL-6 was 61.8±15pg/ml in 5-FU/SIMV and 129.4±17pg/ml in 5-FU/SAL groups. These differences were significant (p<0.05). Mucosal damage in stomach and jejunum were observed in rats receiving 5-FU alone. In the stomach and jejunum, simvastatin caused significant protective effects against 5-FU-induced mucosal injury. Conclusion: simvastatin attenuated gastric and intestinal mucositis related to 5-FU therapeutics in animal model. These data encourage forthcoming clinical studies addressing the usefulness of statins in the prevention and treatment of gastrointestinal mucositis.


Subject(s)
Animals , Male , Rats , Simvastatin/therapeutic use , Mucositis/prevention & control , Fluorouracil/adverse effects , Anti-Inflammatory Agents/therapeutic use , Biomarkers/blood , Random Allocation , Interleukin-6/blood , Rats, Wistar , Intercellular Signaling Peptides and Proteins/blood , Disease Models, Animal , Mucositis/chemically induced , Mucositis/pathology , Interleukin-1beta/blood , Intestinal Mucosa/drug effects , Intestinal Mucosa/pathology
3.
Einstein (Säo Paulo) ; 14(3): 391-397, July-Sept. 2016. tab, graf
Article in English | LILACS | ID: lil-796967

ABSTRACT

ABSTRACT Objective: To evaluate growth factors and cytokines in samples of platelet-rich plasma obtained by three different centrifugation methods. Methods: Peripheral blood of six individuals with no hematological diseases, aged 18 to 68 years, was drawn to obtain platelet-rich plasma, using the open method and commercial columns by Medtronic and Biomet. The products obtained with the different types of centrifugation were submitted to laboratory analysis, including pro-inflammatory cytokines and chemokines by flow cytometry assays, the concentration of fibroblast growth factors-2 (FGF-2) and transforming growth factor-beta1 (TGF-β1). Results: The diverse separation methods generated systematically different profiles regarding number of platelets and leukocytes. The Medtronic system yielded a product with the highest concentration of platelets, and the open method, with the lowest concentration of platelets. The results of cytokine analysis showed that the different types of centrifugation yielded products with high concentrations of interleukin 8, interleukin 1β. The open system resulted in a product with high levels of interleukin 6. Other cytokines and chemokines measured were similar between systems. The product obtained with the open method showed higher levels of TGF-β1 in relation to other systems and low FGF-2 levels. Conclusion: The formed elements, growth factors and cytokines in samples of platelet-rich plasma varied according to the centrifugation technique used.


RESUMO Objetivo: Avaliar fatores de crescimento e citocinas em amostras de plasma rico em plaquetas obtidas por três diferentes métodos de centrifugação. Métodos: Foi coletado sangue periférico de seis indivíduos, sem doença hematológica, com idades entre 18 e 68 anos, para obtenção de plasma rico em plaquetas, utilizando o método aberto e sistemas comerciais das empresas Medtronic e Biomet. Os produtos obtidos com os diferentes tipos de centrifugação foram submetidos às análises laboratoriais, incluindo citocinas próinflamatórias e quimiocinas, por meio de ensaios de citometria de fluxo, concentração do fator de crescimento fibroblástico-2 (FGF-2) e fator de crescimento transformador-beta1 (TGF-β1). Resultados: As diferentes centrifugações geraram perfis sistematicamente diferentes referentes ao número de plaquetas e de leucócitos. O sistema da Medtronic originou produto com a maior concentração de plaquetas, e o método aberto com a menor concentração de plaquetas. Os resultados da análise de citocinas demonstraram que os diferentes tipos de centrifugação originaram produtos com elevadas concentrações de interleucina 8 e interleucina 1β. O sistema aberto resultou em produto com elevados níveis de interleucina 6. As demais citocinas e quimiocinas mensuradas foram similares entre os sistemas. O produto obtido com o método aberto apresentou níveis superiores de TGF-β1 em relação aos demais sistemas e reduzidos níveis de FGF-2. Conclusão: Os elementos figurados, fatores de crescimento e citocinas, em amostras de plasma rico em plaquetas, variaram conforme a técnica de centrifugação utilizada.


Subject(s)
Humans , Adolescent , Adult , Middle Aged , Aged , Young Adult , Cytokines/analysis , Intercellular Signaling Peptides and Proteins/analysis , Platelet-Rich Plasma/chemistry , Centrifugation/methods , Cytokines/blood , Interleukins/analysis , Interleukins/blood , Chemokines/analysis , Chemokines/blood , Intercellular Signaling Peptides and Proteins/blood , Rotator Cuff Injuries/surgery
4.
Gut and Liver ; : 109-116, 2016.
Article in English | WPRIM | ID: wpr-111610

ABSTRACT

BACKGROUND/AIMS: Levels of serum apelin (s-apelin), an endogenous ligand for angiotensin-like receptor 1, have been shown to be related to hepatic fibrosis and hemodynamic abnormalities in preclinical studies. We investigated the clinical implications of s-apelin as a noninvasive prognostic biomarker for chronic liver disease (CLD). METHODS: From January 2009 to December 2012, 215 CLD patients were enrolled and underwent clinical data collection, hepatic venous pressure gradient (HVPG) measurement, and liver biopsy. s-apelin was detected with a human total apelin enzyme-linked immunosorbent assay kit. All patients were prospectively observed during the median follow-up period of 23.0±12.9 months for decompensation and mortality. RESULTS: A total of 42 patients (19.5%) died during the follow-up period. s-apelin was significantly correlated with measurements of liver stiffness (R2=0.263, p<0.001) and collagen proportional area (R2=0.213, p<0.001) measured from liver biopsy tissue and HVPG (R2=0.356, p<0.001). In a multivariate analysis using a Cox regression hazard model, s-apelin was a weakly significant predictor of decompensation (hazard ratio [HR], 1.002; p<0.001) and mortality (HR, 1.003; p<0.001). CONCLUSIONS: s-apelin showed a significant relationship with CLD severity. However, its significance as a noninvasive biomarker for disease severity and prognosis was weak.


Subject(s)
Adult , Biomarkers/blood , Biopsy , Enzyme-Linked Immunosorbent Assay , Female , Follow-Up Studies , Humans , Hypertension, Portal/blood , Intercellular Signaling Peptides and Proteins/blood , Liver/blood supply , Liver Cirrhosis/blood , Male , Middle Aged , Portal Pressure , Prognosis , Proportional Hazards Models , Prospective Studies
5.
Article in English | WPRIM | ID: wpr-34228

ABSTRACT

Chemerin is a recently identified adipokine suggested to play a role in obesity and its metabolic complications. The relationship between visceral obesity and serum chemerin levels in type 2 diabetes (T2DM) is unknown and may differ from that of subjects without diabetes. Therefore, we evaluated whether serum chemerin was associated with visceral abdominal obesity in patients with T2DM. A total of 218 Korean patients with T2DM were enrolled and metabolic parameters, abdominal visceral and subcutaneous fat areas, and serum chemerin levels were measured. Serum chemerin level showed positive correlation with fasting insulin, HOMA-IR, serum triglyceride, serum creatinine, urine albumin/creatinine ratio, high-sensitivity C-reactive protein (hsCRP), fibrinogen, abdominal visceral fat area, visceral to subcutaneous fat area ratio, and negatively correlation with high density lipoprotein cholesterol and creatinine clearance (CCr) after adjusting for age, gender and body mass index. Multiple linear stepwise regression analysis showed that abdominal visceral fat area (β = 0.001, P < 0.001), serum triglyceride (β = 0.001, P < 0.001), CCr (β = -0.003, P = 0.001), hsCRP (β = 0.157, P = 0.001), fibrinogen (β = 0.001, P < 0.001) and BMI (β = 0.02, P = 0.008) independently affected log transformed serum chemerin levels. Higher serum chemerin level was associated with higher level of abdominal visceral fat area, serum triglyceride, hsCRP and fibrinogen and lower level of CCr in patients with T2DM. Serum chemerin may be used as a biomarker of visceral adiposity and chemerin may play a role in inflammation, decreased renal function, and increased cardiovascular risk in T2DM.


Subject(s)
Adult , Biomarkers/blood , Body Mass Index , C-Reactive Protein/analysis , Chemokines/blood , Creatinine/blood , Diabetes Mellitus, Type 2/blood , Female , Humans , Insulin/blood , Intercellular Signaling Peptides and Proteins/blood , Intra-Abdominal Fat/pathology , Linear Models , Lipocalins/blood , Male , Middle Aged , Obesity/complications , Triglycerides/blood
6.
Yonsei Medical Journal ; : 1296-1306, 2015.
Article in English | WPRIM | ID: wpr-185891

ABSTRACT

PURPOSE: Dickkopf-1 (DKK-1) is a Wnt/beta-catenin signaling pathway inhibitor. We investigated whether DKK-1 is related to progression in hepatocellular carcinoma (HCC) cells and HCC patients. MATERIALS AND METHODS: In vitro reverse-transcription polymerase chain reaction (RT-PCR), wound healing assays, invasion assays, and ELISAs of patient serum samples were employed. The diagnostic accuracy of the serum DKK-1 ELISA was assessed using receiver operating characteristic (ROC) curves and area under ROC (AUC) analyses. RESULTS: RT-PCR showed high DKK-1 expression in Hep3B and low in 293 cells. Similarly, the secreted DKK-1 concentration in the culture media was high in Hep3B and low in 293 cells. Wound healing and invasion assays using 293, Huh7, and Hep3B cells showed that DKK-1 overexpression promoted cell migration and invasion, whereas DKK-1 knock-down inhibited them. When serum DKK-1 levels were assessed in 370 participants (217 with HCC and 153 without), it was significantly higher in HCC patients than in control groups (median 1.48 ng/mL vs. 0.90 ng/mL, p0.05). When three biomarkers were combined (DKK-1 plus AFP plus DCP), they showed significantly higher AUC (AUC=0.952) than single marker, DKK-1 plus AFP, or DKK-1 plus DCP (all p<0.001). CONCLUSION: DKK-1 might be a key regulator in HCC progression and a potential therapeutic target in HCC. Serum DKK-1 could complement the diagnostic accuracy of AFP and DCP.


Subject(s)
Area Under Curve , Biomarkers/blood , Biomarkers, Tumor/blood , Carcinoma, Hepatocellular/blood , Enzyme-Linked Immunosorbent Assay , Female , Humans , Intercellular Signaling Peptides and Proteins/blood , Liver Neoplasms/blood , Male , Middle Aged , Protein Precursors/blood , Prothrombin/metabolism , ROC Curve , Reverse Transcriptase Polymerase Chain Reaction/methods , Sensitivity and Specificity , alpha-Fetoproteins/analysis
7.
Clinics ; 69(10): 688-693, 10/2014. tab
Article in English | LILACS | ID: lil-730465

ABSTRACT

OBJECTIVES: New bone formation is one of the hallmark characteristics of ankylosing spondylitis, which is thereby associated with syndesmophytes. Fetuin-A is a molecule that is abundantly found in calcified tissues and it shows high affinity for calcium phosphate minerals and related compounds. Considering the role of fetuin-A in the regulation of calcified matrix metabolism, we compared the fetuin-A levels in ankylosing spondylitis patients with syndesmophytes with those in patients without syndesmophytes and in healthy controls. We also studied other biomarkers that are thought to be related to syndesmophytes. METHODS: Ninety-four patients (49 patients without syndesmophytes, 67.3% male, 40.7±8.7 years; 45 patients with syndesmophytes, 71.1% M, 43.9±9.9 years) and 68 healthy controls (44.2±10.6 years and 70.6% male) were included in this study. Syndesmophytes were assessed on the lateral radiographs of the cervical and lumbar spine. The serum levels of fetuin-A, dickkopf-1, sclerostin, IL-6, high-sensitivity C-reactive protein and bone morphogenetic protein-7 were measured with an enzyme-linked immunosorbent assay. RESULTS: Patients with syndesmophytes had significantly higher levels of fetuin-A compared with patients without syndesmophytes and controls (1.16±0.13, 1.05±0.09 and 1.08±0.13 mg/ml, respectively). However, fetuin-A was not different between the patients without syndesmophytes and controls. Bone morphogenetic protein-7 was significantly lower; dickkopf-1 was significantly higher in patients with ankylosing spondylitis compared with controls. The sclerostin concentrations were not different between the groups. In regression analysis, fetuin-A was an independent, significant predictor of syndesmophytes. CONCLUSION: Our results suggest that fetuin-A may a role in the pathogenesis of bony proliferation in ankylosing spondylitis. .


Subject(s)
Adult , Female , Humans , Male , Middle Aged , Ossification, Heterotopic/metabolism , Spondylitis, Ankylosing/metabolism , /analysis , Analysis of Variance , Biomarkers/blood , /blood , Bone Morphogenetic Proteins/blood , C-Reactive Protein/analysis , Case-Control Studies , Cervical Vertebrae/metabolism , Cervical Vertebrae , Enzyme-Linked Immunosorbent Assay , Genetic Markers , Intercellular Signaling Peptides and Proteins/blood , /blood , Lumbar Vertebrae/metabolism , Lumbar Vertebrae , Ossification, Heterotopic/pathology , Reference Values , Statistics, Nonparametric , Spondylitis, Ankylosing/pathology , /metabolism
8.
Egyptian Rheumatologist [The]. 2012; 34 (3): 111-117
in English | IMEMR | ID: emr-170393

ABSTRACT

Dickkopf-1 [DKK-1] is an inhibitory molecule that regulates Wnt pathway, which is critically important in osteoblastic new bone formation, therefore it may play a role in the process of new bone formation in Ankylosing Spondylitis [AS]. To measure serum level of DKK-1 in AS patients and study the relation between these levels with disease activity, spinal dysmobility and radiographic findings. Thirty AS patients as well as 20 healthy subjects as a control group were included in this study. DKK-1 serum levels were measured using ELISA technique, disease activity was assessed using Bath Ankylosing Spondylitis Disease Activity Index [BASDAI] score, radiographic assessment by Bath Ankylosing Spondylitis Radiology Index-spine [BASRI-s] and modified Stoke Ankylosing Spondylitis Spinal Score [mSASSS]. DKK-1 was not correlated to ESR, CRP or BASDAI [p > 0.05] and was negatively correlated to BASRI-s and mSASSS [p < 0.001], though DKK-1 serum level was unexpectedly higher in patients versus control [p < 0.001]. On comparing HLA-B27 positive and HLA-B27 negative patients, there were a significant increase in BASRI-s and mSASSS and decrease in DKK-1 level in those with positive HLA-B27 [p < 0.05]. On comparing patients received anti TNF therapy and those not received anti TNF therapy, there was no significant difference in DKK-1 level [p > 0.05]. Our finding suggests dysfunction of DKK-1 in patient with AS


Subject(s)
Humans , Male , Female , Intercellular Signaling Peptides and Proteins/blood , Interferons
9.
EJB-Egyptian Journal of Biochemistry and Molecular Biology [The]. 2011; 29 (1): 195-216
in English | IMEMR | ID: emr-117216

ABSTRACT

Chronic renal failure has been associated with impaired immunity and subclinical inflammation involving cytokines derived from adipose tissue - adipocytokines. Deteriorating renal function may increase overall inflammatory responses because of the decreased renal clearance of factors that are directly or indirectly involved in inflammation. Declining renal function may also affect the levels of additional inflammatory molecules such as C-reactive protein [CRP] and interleukin-6.The aim of the study was to assess visfatin and apelin in correlation with markers of endothelial cell injury and inflammation in 20 patients with CRF and 20 age- and sex-matched healthy controls.We assessed visfatin and apelin, markers of: coagulation: TAT [thrombin-antithrombin complexes]; fibrinolysis: tPA [tissue plasminogen activator] and PAI-1 [plasminogen activator inhibitor-1]; endothelial function/injury: 1CAM [intracellular adhesion molecule], VCAM [vascular cell adhesion molecule], CD40L and E-selectin and inflammation: hsCRP andIL-lbeta. Visfatin, apelin, TAT, ICAM, VCAM, CD40L, PAI-1, E-selectin, hsCRP, IL-lbeta and triglycerides were elevated while serum albumin and t-PA were decreased in CRF patients when compared with the control group.Significant positive correlations were found between visfatin on one hand and each of apelin, t-PA, PAI-1, E-selectin, ICAM, VCAM, hsCRP, LL-lbeta, CD40L and triglycerides on the other hand in patients with CRF.Also, Significant positive correlations were found between Apelin and each of EL-lbeta, E-selectin, ICAM, VCAM, creatinine and triglycerides in CRF


Subject(s)
Humans , Male , Female , Adipokines/blood , Tissue Plasminogen Activator/blood , Vascular Cell Adhesion Molecule-1/blood , Intercellular Signaling Peptides and Proteins/blood , /blood , E-Selectin/blood
10.
Article in English | WPRIM | ID: wpr-28042

ABSTRACT

DKK1 modulates Wnt signaling, which is involved in the atherosclerosis. However, no data exist regarding the usefulness of measuring serum DKK1 concentration in predicting coronary atherosclerosis. A total of 270 consecutive patients (62.8 +/- 11.2 yr; 70% male) were included. A contrast-enhanced 64-slice coronary MDCT was performed to identify the presence of atherosclerotic plaques. Agatston calcium scores (CS) were calculated to quantify the coronary artery calcification (CAC). DKK1 concentrations were measured by enzyme-linked immunosorbent assay. For each subsequent DKK1 quartile, there was a significant increase in CAC (P = 0.004) and the number of segments with coronary atherosclerosis (P or = 68.6 pg/mL demonstrated coronary atherosclerotic plaques even when they had low CS. Serum DKK1 concentrations correlate with the coronary atherosclerosis and play an independent role in predicting the presence of coronary atherosclerosis.


Subject(s)
Adult , Aged , Aged, 80 and over , Biomarkers/blood , Calcinosis/blood , Coronary Artery Disease/blood , Female , Humans , Intercellular Signaling Peptides and Proteins/blood , Male , Middle Aged , Odds Ratio , Plaque, Atherosclerotic/blood , Predictive Value of Tests , Risk Factors , Severity of Illness Index , Tomography, X-Ray Computed
11.
Article in English | WPRIM | ID: wpr-53833

ABSTRACT

We investigated the association between nonalcoholic fatty liver disease (NAFLD) and plasma adiponectin levels and insulin resistance. We recruited study subjects among one hundred and eighty one persons who were examined abdominal ultrasound at routine screening tests. A standard interview (consumption of alcohol and medical history), physical examination (height, weight, waist circumference, and blood pressure), and biochemical study (lipid parameters, aminotransferases, fasting plasma glucose, fasting insulin, and plasma adiponectin) were performed. Subjects who consumed alcohol more than moderate, evidence of viral hepatitis, toxic hepatitis, and serious cardiac, renal, or hepatic disease were excluded. Thirty-eight NAFLD patients and 53 control subjects diagnosed by ultrasound were finally analyzed. The plasma adiponectin level was significantly correlated with HDL-cholesterol (r=0. 38, p<0.001), triglycerides (r=-0.22, p=0.04), fasting insulin (r=-0.37, p<0.01), and insulin resistance by homeostasis model of assessment-insulin resistance (HOMAIR) (r=-0.39, p<0.01), after adjusting for age, sex, and adiposity. Multiple logistic regression analysis indicated that HOMA-IR was a significant predictor of having NAFLD (odds ratio [OR]=2.38; 95% confidence interval [CI]: 1.52-5.74), while adiponectin had a protective effect against NAFLD (OR=0.22; 95% CI: 0.09-0.55). We demonstrated that hypoadiponectinemia and insulin resistance are associated with NAFLD independent of obesity.


Subject(s)
Adult , Alanine Transaminase/blood , Aspartate Aminotransferases/blood , Blood Glucose/metabolism , Blood Pressure , Body Mass Index , Cholesterol/blood , Comparative Study , Fatty Liver/blood , Female , Humans , Insulin Resistance/physiology , Intercellular Signaling Peptides and Proteins/blood , Logistic Models , Male , Middle Aged , Multivariate Analysis , Triglycerides/blood
12.
Yonsei Medical Journal ; : 42-50, 2005.
Article in English | WPRIM | ID: wpr-35934

ABSTRACT

Insulin resistance, which implies impairment of insulin signaling in the target tissues, is a common cause of type 2 diabetes. Adipose tissue plays an important role in insulin resistance through the dysregulated production and secretion of adipose-derived proteins, including tumor necrosis factor-alpha, plasminogen activator inhibitor-1, leptin, resistin, angiotensinogen, and adiponectin. Adiponectin was estimated to be a protective adipocytokine against atherosclerosis, and also to have an anti-inflammatory effect. In this study, the relationship between fasting plasma adiponectin concentration and adiposity, body composition, insulin sensitivity (ITT, HOMAIR, QUICK), lipid profile, fasting insulin concentration were examined in Korean type 2 diabetes. The difference in the adiponectin concentrations was also examined in diabetic and non-diabetic subjects, with adjustment for gender, age and body mass index. 102 type 2 diabetics and 50 controls were examined. After a 12-h overnight fast, all subjects underwent a 75gram oral glucose tolerance test. Baseline blood samples were drawn for the determinations of fasting plasma glucose, insulin, adiponectin, total cholesterol, triglyceride, LDL-cholesterol, and HDL-cholesterol. The body composition was estimated using a bioelectric impedance analyzer (Inbody 2.0). The insulin sensitivity was estimated using the insulin tolerance test (ITT), HOMAIR and QUICK methods. In the diabetic group, the fasting adiponectin concentrations were significantly lower in men than in women. They were negatively correlated with BMI (r=-0.453), hip circumference (r=-0.341), fasting glucose concentrations (r=-0.277) and HOMAIR (r=-0.233). In addition, they were positively correlated with systolic blood pressure (r=0.321) and HDL-cholesterol (r= 0.291). The systolic blood pressure and HDL-cholesterol were found to be independent variables, from a multiple logistic regression analysis, which influenced the adiponectin concentration. Compared with the non-diabetic group, the adiponectin concentrations were significantly lower in the diabetic group, with the exception of obese males. In conclusion, the plasma adiponectin concentrations were closely related to the insulin resistance parameters in Korean type 2 diabetic patients.


Subject(s)
Adult , Aged , Biomarkers , Diabetes Mellitus, Type 2/blood , Female , Humans , Insulin Resistance , Intercellular Signaling Peptides and Proteins/blood , Korea , Male , Middle Aged
13.
Scientific Journal of Al-Azhar Medical Faculty [Girls] [The]. 2004; 25 (3): 781-794
in English | IMEMR | ID: emr-104946

ABSTRACT

Transforming growth factor - alpha [TGF-alpha] and insulin -growth factor - II [IGF-II] are important autocrine growth factors of hepatocytes. They are potent stimulators of cell. proliferation in the liver and in liver tumors. TGF-alpha and IGF-Il are over expressed in hepatic malignant tissues, and elevated serum levels can be indicator of tumor activity in addition to conventional tumor markers. Our aim was to evaluate the role of TGF-alpha together with IGF-Il in the diagnostic work - up of patients with heptocellular carcinoma [HCC]. Thirty patients with liver cirrhosis [LC], 30 with hepatocellular carcinoma [HCC] and 24 normal controls [C] were enrolled in this study- Serum TGF-alpha and IGF-II levels were measured by enzyme - linked immunosorbent assay. TGF-alpha and IGF-II serum levels were significantly elevated in cirrhotic patients [P<0.05 as compared to control] and over expressed significantly in HCC patients [P<0.001 in comparison with both cirrhotic and control groups]. Both parameters showed positive correlation in the cirrhotic group [P<0.001, r=0.886], while in the HCC group: TGF-alpha and IGF-Il showed positive correlation with each other [P<0.001, r = 0.908] and also with alpha-fetoprotein [AFP] [P< 0.001, r = 0.884 and P<0.001, r =0.881 respectively]. Child C class showed the highest levels of TGF-alpha and IGF-Il in both cirrhotic and HCC groups. All patients showed HBs Ag and /or HCVAb positivity in their serum. Hepatitis B and C viruses infection is closely related with hepatocarcinogenesis. The over expression of TGF-alpha and IGF-Il in the liver and serum seem tobe associated with the regeneration of hepatocytes injured by HBsAg or/and HCV. The continued expression of TGF-alpha and IGF-II might lead to dysplasia of liver cells and development of HCC- Therefore, in addition to AFP; TGF-alpha and IGF-Il appear to be suitable markers for the evaluation of the serological status of HCC patients


Subject(s)
Humans , Male , Female , Liver Cirrhosis , Transforming Growth Factor alpha/blood , Insulin-Like Growth Factor II , Intercellular Signaling Peptides and Proteins/blood
14.
Article in English | WPRIM | ID: wpr-29052

ABSTRACT

We investigated whether the production and gene expression of Gro-alpha and RANTES in Kawasaki disease differ in measles. Forty-two samples from 14 patients in different clinical stages of Kawasaki disease, eight samples from 8 patients in the acute stage of measles and seven samples from 7 healthy children were collected. The present study was performed using ELISA and RT-PCR for the productions and gene expression of the chemokines. The production of Gro-alpha was markedly elevated during the acute stage of measles compared with Kawasaki disease. Moreover, the expression of Gro-alpha was increased in every case of measles, but not in Kawasaki disease. The production of RANTES was elevated in the acute stage of both diseases when compared to the healthy control. However, the plasma RANTES level did not change significantly according to the clinical stages of Kawasaki disease. A correlation between the production and gene expression of RANTES and Gro-alpha was not found in Kawasaki disease. These results suggest that Kawasaki disease differs from measles with regard to Gro-alpha production and expression, but not RANTES. Gro-alpha might play an important role in the acute stage of measles, however not in Kawasaki disease. Further studies are needed to clarify the efficacy of Gro-alpha as a marker in measles.


Subject(s)
Biomarkers , Chemokines/blood , Chemotactic Factors/blood , Child , Child, Preschool , Comparative Study , Female , Gene Expression/immunology , Humans , Infant , Intercellular Signaling Peptides and Proteins/blood , Leukocytes, Mononuclear/physiology , Male , Measles/immunology , Mucocutaneous Lymph Node Syndrome/immunology , Chemokine CCL5/blood , RNA, Messenger/analysis
SELECTION OF CITATIONS
SEARCH DETAIL